General Surgery and Transplant Unit, Department of General Surgery and Organ Transplantation, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Hepatobiliary Pancreat Dis Int. 2012 Oct;11(5):507-12. doi: 10.1016/s1499-3872(12)60215-x.
Postoperative hepatic failure is a dreadful complication after major hepatectomy and carries high morbidity and mortality rates. In this study, we assessed the accuracy of the 50/50 criteria (bilirubin >2.9 mg/dL and international normalized ratio >1.7 on postoperative day 5) and the Mullen criteria (bilirubin peak >7 mg/dL on postoperative days 1-7) in predicting death from hepatic failure in patients undergoing right hepatectomy only. In addition, we identified prognostic factors linked to intra-hospital morbidity and mortality in these patients.
One hundred seventy consecutive patients underwent major right hepatectomy at a tertiary medical center from 2000 to 2008. Nineteen (11.2%) patients suffered from liver cirrhosis. Univariate and multivariate analyses were performed to identify predictors of intra-hospital mortality, morbidity and death from hepatic failure.
The intra-hospital mortality was 6.5% (11/170). Of the six patients who died from hepatic failure, one was positive for the 50/50 criteria, but all six patients were positive for the Mullen criteria. Multivariate analysis showed that male gender, hepatitis C (HCV), hepatocellular carcinoma, postoperative bilirubin >7 mg/dL and ALT<188 U/L on postoperative day 1 were predictive of death from hepatic failure in the postoperative period. Age >65 years, HCV, reoperation, and renal failure were significant predictors of overall intra-hospital mortality on multivariate analysis.
The Mullen criteria were more accurate than the 50/50 criteria in predicting death from hepatic failure in patients undergoing right hepatectomy. A bilirubin peak >7 mg/dL in the postoperative period, HCV positivity, hepatocellular carcinoma, and an ALT level <188 U/L on postoperative day 1 were associated with death from hepatic failure in our patient population.
术后肝功能衰竭是肝切除术后一种严重的并发症,具有较高的发病率和死亡率。在这项研究中,我们评估了 50/50 标准(术后第 5 天胆红素>2.9mg/dL 和国际标准化比值>1.7)和 Mullen 标准(术后第 1-7 天胆红素峰值>7mg/dL)在预测仅行右半肝切除患者肝功能衰竭死亡中的准确性。此外,我们确定了与这些患者院内发病率和死亡率相关的预后因素。
2000 年至 2008 年,在一家三级医学中心,170 例连续患者接受了主要的右半肝切除术。19 例(11.2%)患者患有肝硬化。进行了单因素和多因素分析,以确定院内死亡率、发病率和肝功能衰竭死亡的预测因素。
院内死亡率为 6.5%(11/170)。在 6 例死于肝功能衰竭的患者中,1 例符合 50/50 标准,但所有 6 例均符合 Mullen 标准。多因素分析显示,男性、丙型肝炎(HCV)、肝细胞癌、术后第 1 天胆红素>7mg/dL 和丙氨酸转氨酶(ALT)<188U/L 是术后肝功能衰竭死亡的预测因素。年龄>65 岁、HCV、再次手术和肾衰竭是多因素分析中整体院内死亡率的显著预测因素。
Mullen 标准比 50/50 标准更能准确预测行右半肝切除术患者肝功能衰竭的死亡。在我们的患者群体中,术后胆红素峰值>7mg/dL、HCV 阳性、肝细胞癌和术后第 1 天 ALT 水平<188U/L 与肝功能衰竭死亡相关。